Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

289.03
Delayed Data
As of 3:59pm ET
 +0.68 / +0.24%
Today’s Change
223.02
Today|||52-Week Range
338.51
-5.65%
Year-to-Date
The Zacks Analyst Blog Highlights: Biogen, Gilead, AbbVie, Amgen and Celgene
10:07am / Zacks.com - Paid Partner Content
Biogen (BIIB) Stock Up on CEO Transition, Fueling Sale Speculation
Jul 22 / TheStreet.com - Paid Partner Content
Amgen (AMGN) Tops Q2 Earnings & Revenues, Raises View
8:40am / Zacks.com - Paid Partner Content
Biogen Should Either a Buyer or a Seller Be
Jul 22 / TheStreet.com - Paid Partner Content
Vertex (VRTX) Posts Narrower Q2 Loss, Revenues Fall Short
7:51am / Zacks.com - Paid Partner Content
Biogen Inc: How Double-Digit Growth Got Trumped
Jul 22 / MotleyFool.com - Paid Partner Content
2 Large Cap Drug Stocks to Watch for Earnings: ABBV & MRK
7:31am / Zacks.com - Paid Partner Content
Medical Stocks Reporting Early Next Week: GILD, LLY & More
Jul 22 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Biogen Q2 Results Impress, Gilead HCV Franchise Under Pressure
Jul 27 / Zacks.com - Paid Partner Content
Stock Market News for July 21, 2016
Jul 21 / Zacks.com - Paid Partner Content
5 Undervalued Growth Stocks to Buy Today
Jul 27 / MotleyFool.com - Paid Partner Content
Q2 Earnings Central Stays Busy, GM Sets New Record
Jul 21 / Zacks.com - Paid Partner Content
Watch for Drug Stocks Earnings on Jul 28: BMY, CELG & More
Jul 27 / Zacks.com - Paid Partner Content
Biogen (BIIB) Stock Up on Q2 Earnings Beat, Raised Outlook
Jul 21 / Zacks.com - Paid Partner Content
Experimental Tau Protein Drug Tangled Up in Late-Stage Alzheimer's Study Failure
Jul 27 / TheStreet.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Zafgen, Celgene, Amgen, AbbVie and Biogen
Jul 21 / Zacks.com - Paid Partner Content
5 Drug Stocks' Earnings on Jul 27: AMGN, VRTX & More
Jul 26 / Zacks.com - Paid Partner Content
Biogen (BIIB) Beats on Q2 Earnings by a Huge Margin
Jul 21 / Zacks.com - Paid Partner Content
An Investing Overview of the Multiple Sclerosis Market
Jul 26 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Celgene in Immuno-Oncology Deal, Zafgen Drops Lead Drug
Jul 20 / Zacks.com - Paid Partner Content
Where Is the Insider Buying?
Jul 25 / TheStreet.com - Paid Partner Content
Medical Stocks to Post Earnings This Week: ABT, BIIB, ALIOF
Jul 19 / Zacks.com - Paid Partner Content
Fresh Research Reports For Intel (INTC), AT&T (T) & Others
Jul 25 / Zacks.com - Paid Partner Content
4 Rock-Solid, Cheap Biotech Stocks
Jul 16 / MotleyFool.com - Paid Partner Content
I'm Bullish on Biotechs
Jul 25 / TheStreet.com - Paid Partner Content
Biogen (BIIB) Q2 Earnings: Will the Stock Disappoint?
Jul 15 / Zacks.com - Paid Partner Content
Zacks Industry Outlook Highlights: Bristol-Myers, Pfizer, Sanofi, Amgen and Biogen
Jul 25 / Zacks.com - Paid Partner Content
Does Biogen's Lower P/E Ratio Make It a Better Buy Than Celgene?
Jul 15 / MotleyFool.com - Paid Partner Content
What's in Store for these 5 Drug Stocks in Q2 Earnings?
Jul 25 / Zacks.com - Paid Partner Content
Biosimilars set topple two of the world's biggest drug franchises
Jul 14 / FT.com - Paid Partner Content
Pharma Industry Outlook: Fundamentals Remain Strong
Jul 22 / Zacks.com - Paid Partner Content